
Prestige Consumer Healthcare fell 21.7% from $58.98 to $46.19, behind the S&P 500's +13.3%. Its worst day was Nov 5 (−16.8%), and its low came Nov 6 at $42.98.
Nov 17, 2025 – Nov 13, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $1.14 missed the $1.16 estimate on $283.4M revenue (est. $284.8M); FY revenue guidance of $1.1B against the $1.1B consensus.
−2.2% · S&P 500 −1.2%
Story events cover the past 12 months · Times ET
Prestige Consumer Healthcare closed at its highest level of the year, 19.0% above where the year started.
+1.2% · S&P 500 −0.6%
Prestige Consumer Healthcare shares fell 9.0%, while the S&P 500 rose 0.1%.
−9.0% · S&P 500 +0.1%
EPS of $1.23 missed the $1.40 estimate on $281.6M revenue (est. $293.8M); FY revenue guidance of $1.1B–$1.1B against the $1.2B consensus.
−11.3%, on 2M shares, the year's heaviest volume · S&P 500 +0.8%
EPS of $0.98 beat the $0.87 estimate on $265.7M revenue (est. $250.1M); FY revenue guidance of $1.3B–$1.3B against the $1.2B consensus.
+2.7% · S&P 500 −0.2%
EPS of $1.13 beat the $1.07 estimate on $336.3M revenue (est. $329.0M); FY revenue guidance of $1.3B–$1.3B against the $1.3B consensus.
−16.8%, the year's worst day · S&P 500 −4.4%
Where it ended: a close of $46.19 on Nov 13, 2026. Up next: Q3 2027 earnings on Feb 4, 2027 (EPS est. $1.07, revenue est. $330.2M).
Nothing in the past 12 months.
All PBH dividend historyAs of the Nov 13, 2026 close
Replay the year: the line draws itself and stops at each of the 6 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for PBH and SPY from Benzinga historical bars. Not investment advice.